Literature DB >> 23715996

Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.

Jae Seung Lee1, Seon Ok Kim, Joon Beom Seo, Ji-Hyun Lee, Eun Kyung Kim, Tae-Hyung Kim, Woo Jin Kim, Jin Hwa Lee, Sang-Min Lee, Sangyeub Lee, Seong Yong Lim, Tae Rim Shin, Ho Il Yoon, Sei Won Lee, Jin Won Huh, Yeon-Mok Oh, Sang-Do Lee.   

Abstract

BACKGROUND: The progression of lung hyperinflation in patients with chronic obstructive pulmonary disease (COPD) has not been studied in a long-term prospective cohort. We explored the longitudinal changes in lung volume compartments with the aim of identifying predictors of a rapid decline of the inspiratory capacity to total lung capacity ratio (IC/TLC).
METHODS: The study population comprised 324 patients with COPD who were recruited prospectively. Annual rates of changes in pulmonary function, including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), total lung capacity (TLC), functional residual capacity (FRC), residual volume (RV), vital capacity (VC), IC, and IC/TLC, were estimated using the random coefficient models.
RESULTS: The mean annual rates of changes in pre- and post-bronchodilator FEV1 were -23.0 mL/year (p < 0.001) and -26.5 mL/year (p = 0.004). The mean annual rates of changes in VC, IC, TLC, and IC/TLC were -33.7 mL/year (p = 0.007), -53.9 mL/year (p < 0.001), -43.7 mL/year (p = 0.012), and -0.65%/year (p = 0.001), respectively. RV, FRC, and RV/TLC did not change significantly during the study period. Multivariate logistic regression analysis showed that a high modified Medical Research Council (MMRC) dyspnea scale score, a high Charlson comorbidity index value, and low post-bronchodilator FEV1 were associated with rapid decline in IC/TLC.
CONCLUSION: MMRC dyspnea scale, post-bronchodilator FEV1, and the Charlson comorbidity index at baseline were independent predictors of a rapid decline in IC/TLC.

Entities:  

Mesh:

Year:  2013        PMID: 23715996     DOI: 10.1007/s00408-013-9478-0

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  28 in total

Review 1.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

Review 2.  On the causes of lung hyperinflation during bronchoconstriction.

Authors:  R Pellegrino; V Brusasco
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

3.  Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD.

Authors:  Roberto Duranti; Mario Filippelli; Roberto Bianchi; Isabella Romagnoli; Riccardo Pellegrino; Vito Brusasco; Giorgio Scano
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

Review 4.  The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.

Authors:  Christopher B Cooper
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

5.  Gender and COPD in patients attending a pulmonary clinic.

Authors:  Juan P de Torres; Ciro Casanova; Concepción Hernández; Juan Abreu; Armando Aguirre-Jaime; Bartolome R Celli
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

6.  Smoking and lung function of Lung Health Study participants after 11 years.

Authors:  Nicholas R Anthonisen; John E Connett; Robert P Murray
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

7.  A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.

Authors:  D A Mahler; A Harver
Journal:  Am Rev Respir Dis       Date:  1992-02

8.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Authors:  Bartolomé R Celli; Nicola E Thomas; Julie A Anderson; Gary T Ferguson; Christine R Jenkins; Paul W Jones; Jørgen Vestbo; Katharine Knobil; Julie C Yates; Peter M A Calverley
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

9.  Changes in forced expiratory volume in 1 second over time in COPD.

Authors:  Jørgen Vestbo; Lisa D Edwards; Paul D Scanlon; Julie C Yates; Alvar Agusti; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; William MacNee; Bruce E Miller; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Stephen I Rennard
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

10.  Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Marc Decramer; Theodore Lystig; Steven Kesten; Donald P Tashkin
Journal:  Respir Res       Date:  2012-08-06
View more
  4 in total

1.  Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study.

Authors:  Hui Zhang; Xia Li; Lixue Huang; Xiaoyin Gu; Yimin Wang; Min Liu; Zhibo Liu; Xueyang Zhang; Zhenxing Yu; Yeming Wang; Chaolin Huang; Bin Cao
Journal:  EClinicalMedicine       Date:  2022-09-28

2.  Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.

Authors:  Ha Youn Lee; Sun Mi Choi; Jinwoo Lee; Young Sik Park; Chang-Hoon Lee; Deog Kyeom Kim; Sang-Min Lee; Ho Il Yoon; Jae-Joon Yim; Young Whan Kim; Sung Koo Han; Chul-Gyu Yoo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-13

3.  Efficacy and Safety of Roflumilast in Korean Patients with COPD.

Authors:  Jae Seung Lee; Yoon Ki Hong; Tae Sun Park; Sei Won Lee; Yeon Mok Oh; Sang Do Lee
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

4.  Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.

Authors:  Sally Singh; François Maltais; Lee Tombs; William A Fahy; Mitra Vahdati-Bolouri; Nicholas Locantore; John H Riley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.